Last updated: April 24, 2026

Application No. 19/419,518

Untitled Application

Unknown

Filed

1600

Examiner

SHIAO, REI TSANG

Art Unit

1691

Tech Center

Novo Nordisk A/S

Assignee

Novo Nordisk A/S

OA Round

1 (Non-Final)

Interview Optional

— -34.9% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 2019 resolved cases, 2023–2026

Examiner Intelligence

SHIAO, REI TSANG View full profile →

Grants 80% — above average

Career Allow Rate

1612 granted / 2019 resolved

+19.8% vs TC avg

Minimal -35% lift

Without

With

+-34.9%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

53 currently pending

Career history

2072

Total Applications

across all art units

Statute-Specific Performance

§101

0.7%

-39.3% vs TC avg

§103

29.1%

-10.9% vs TC avg

§102

8.1%

-31.9% vs TC avg

§112

29.6%

-10.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 2019 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 23, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/737,761

Patent 12599580

COMPOSITION COMPRISING A LIPID COMPOUND, A TRIGLYCERIDE, AND A SURFACTANT, AND METHODS OF USING THE SAME

2y 5m to grant Granted Apr 14, 2026

18/019,527

Patent 12600719

SALT INDUCIBLE KINASE INHIBITORS

2y 5m to grant Granted Apr 14, 2026

19/261,853

Patent 12599579

COMPOSITIONS AND COMPOUNDS CONTAINNG KETONE BODIES AND/OR KETONE BODY PRECURSORS AND ONE OR MORE AMINO ACIDS

2y 5m to grant Granted Apr 14, 2026

18/116,506

Patent 12595556

MOLYBDENUM IMIDO ALKYL/ALLYL COMPLEXES FOR DEPOSITION OF MOLYBDENUM-CONTAINING FILMS

2y 5m to grant Granted Apr 07, 2026

18/855,563

Patent 12594254

INTRANASAL ADMINISTRATION OF N-ACETYLCYSTEINE AND USES THEREOF

2y 5m to grant Granted Apr 07, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

80%

Grant Probability

45%

With Interview (-34.9%)

2y 3m

Median Time to Grant

Low

PTA Risk

Based on 2019 resolved cases by this examiner. Grant probability derived from career allow rate.

Untitled Application

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

AI Strategy Recommendation

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email